These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 21670065)
1. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen. Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065 [TBL] [Abstract][Full Text] [Related]
2. Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener's granulomatosis. Kuhl A; Korkmaz B; Utecht B; Kniepert A; Schönermarck U; Specks U; Jenne DE J Immunol; 2010 Jul; 185(1):387-99. PubMed ID: 20530264 [TBL] [Abstract][Full Text] [Related]
3. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293 [TBL] [Abstract][Full Text] [Related]
4. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis. Gross WL; Csernok E; Flesch BK J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690 [TBL] [Abstract][Full Text] [Related]
5. Proteinase 3, Wegener's autoantigen: from gene to antigen. van der Geld YM; Limburg PC; Kallenberg CG J Leukoc Biol; 2001 Feb; 69(2):177-90. PubMed ID: 11272267 [TBL] [Abstract][Full Text] [Related]
6. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. Bini P; Gabay JE; Teitel A; Melchior M; Zhou JL; Elkon KB J Immunol; 1992 Aug; 149(4):1409-15. PubMed ID: 1380042 [TBL] [Abstract][Full Text] [Related]
7. Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation. Gabillet J; Millet A; Pederzoli-Ribeil M; Tacnet-Delorme P; Guillevin L; Mouthon L; Frachet P; Witko-Sarsat V J Immunol; 2012 Sep; 189(5):2574-83. PubMed ID: 22844112 [TBL] [Abstract][Full Text] [Related]
8. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. Williams RC; Staud R; Malone CC; Payabyab J; Byres L; Underwood D J Immunol; 1994 May; 152(9):4722-37. PubMed ID: 8157982 [TBL] [Abstract][Full Text] [Related]
9. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases. Korkmaz B; Jenne DE; Gauthier F Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601 [TBL] [Abstract][Full Text] [Related]
10. Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667 [TBL] [Abstract][Full Text] [Related]
11. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate. Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715 [TBL] [Abstract][Full Text] [Related]
12. Computational prediction of the binding site of proteinase 3 to the plasma membrane. Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025 [TBL] [Abstract][Full Text] [Related]
13. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis. Witko-Sarsat V; Reuter N; Mouthon L Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350 [TBL] [Abstract][Full Text] [Related]
14. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis. Hu N; Westra J; Kallenberg CG Autoimmun Rev; 2009 May; 8(6):510-4. PubMed ID: 19185066 [TBL] [Abstract][Full Text] [Related]
15. Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression system. Szymkowiak CH; Johnston TW; Csernok E; Gross WL Biochem Biophys Res Commun; 1996 Feb; 219(2):283-9. PubMed ID: 8604978 [TBL] [Abstract][Full Text] [Related]
16. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies. van Rossum AP; Rarok AA; Huitema MG; Fassina G; Limburg PC; Kallenberg CG J Leukoc Biol; 2004 Dec; 76(6):1162-70. PubMed ID: 15331626 [TBL] [Abstract][Full Text] [Related]
17. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. van Rossum AP; Limburg PC; Kallenberg CG Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939 [TBL] [Abstract][Full Text] [Related]
18. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease. Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation. Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959 [TBL] [Abstract][Full Text] [Related]
20. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases. Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]